POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection

NCT ID: NCT03400280

Last Updated: 2019-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-08

Study Completion Date

2020-02-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the implementation of a best practice algorithm for postoperative care results in a decrease in incidence of major complications and death after pancreatic resection as compared to current practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale

Pancreatic resection is a major abdominal operation with 50% chance of postoperative complications. A feared complication is severe pancreatic fistula, in which there is leakage of enzyme rich fluid into the abdominal cavity. Adequate complication management appears to be the most important factor in improving outcomes of patients undergoing pancreatic resection.

Objective

To investigate whether implementation of a best practice algorithm for postoperative care focusing on early detection and step-up management of postoperative pancreatic fistula results in a lower rate of major complications and death after pancreatic resection as compared to current practice

Study design

A nationwide stepped-wedge, cluster randomized, superiority trial. In this design all participating centers cross over from current practice to best practice according to the algorithm, but are randomized to determine the exact order. At the end of the trial, all centers will have implemented the best practice algorithm.

Study population

All centers performing pancreatic surgery in the Netherlands (i.e. the Dutch Pancreatic Cancer Group).

Intervention

Cluster level education on postoperative care according to a best practice algorithm, focusing on early detection and step-up management of postoperative pancreatic fistula. This algorithm is based on findings in Dutch observational cohort studies, systematic literature analyses, an inventory in current protocols on postoperative care and expert opinion. The proposed algorithm is validated in a multicenter cohort and consensus upon this algorithm is reached with pancreatic surgeons from all centers of the Dutch Pancreatic Cancer Group. The final algorithm was reviewed critically by the advisory committee of internationally respected experts in the field of pancreatology before implementation in this trial.

Comparison

Postoperative care according to current practice.

Endpoints

The primary outcome was measured in all patients undergoing pancreatic resection and is a composite of major complications (i.e. postpancreatectomy bleeding, new-onset organ failure and death). Secondary endpoints include the individual components of the primary endpoint and other clinical outcomes, number of patients receiving adjuvant chemotherapy, healthcare resource utilization and costs analysis. Follow-up will be 90 days after pancreatic resection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Diseases Pancreatic Neoplasms Pancreatic Cancer Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Stepped-wedge cluster randomized trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Best practice

Postoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.

Group Type EXPERIMENTAL

Best practice algorithm for postoperative care

Intervention Type OTHER

See arm/group description

Current practice

Postoperative care according to current usual practice.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best practice algorithm for postoperative care

See arm/group description

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All Dutch centers performing pancreatic surgery (i.e. performing at least 20 pancreatoduodenectomies a year)


* Patients underoging pancreatic resection for any indication

Exclusion Criteria

* None


* None (i.e. complete enumeration)
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dutch Cancer Society

OTHER

Sponsor Role collaborator

St. Antonius Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

HC van Santvoort

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Quintus Molenaar, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

UMC Utrecht

Hjalmar C van Santvoort, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

St. Antonius Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, , Netherlands

Site Status RECRUITING

Academic Medical Center

Amsterdam, , Netherlands

Site Status RECRUITING

Onze Lieve Vrouwen Gasthuis

Amsterdam, , Netherlands

Site Status RECRUITING

VUmc

Amsterdam, , Netherlands

Site Status RECRUITING

Amphia ziekenhuis

Breda, , Netherlands

Site Status RECRUITING

Reinier de Graaf gasthuis

Delft, , Netherlands

Site Status RECRUITING

Catharina ziekenhuis

Eindhoven, , Netherlands

Site Status RECRUITING

Medisch Spectrum Twente

Enschede, , Netherlands

Site Status RECRUITING

UMCG

Groningen, , Netherlands

Site Status RECRUITING

Tjongerschans

Heerenveen, , Netherlands

Site Status RECRUITING

LUMC

Leiden, , Netherlands

Site Status RECRUITING

Maastricht UMC

Maastricht, , Netherlands

Site Status RECRUITING

Radboud UMC

Nijmegen, , Netherlands

Site Status RECRUITING

Erasmus MC

Rotterdam, , Netherlands

Site Status RECRUITING

Maasstad ziekenhuis

Rotterdam, , Netherlands

Site Status RECRUITING

RAKU (St. Antonius ziekenhuis & UMC Utrecht)

Utrecht, , Netherlands

Site Status RECRUITING

Isala klinieken

Zwolle, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jasmijn Smits, MD

Role: CONTACT

+31887571207

Hjalmar C van Santvoort, MD, PhD

Role: CONTACT

+31887556489

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Koop Bosscha

Role: primary

Marc Besselink

Role: primary

Sebastiaan Festen

Role: primary

Geert Kazemier

Role: primary

Jennifer Schreinemakers

Role: primary

Daphne Roos

Role: primary

Ignace de Hingh

Role: primary

Mike Liem

Role: primary

Vincent de Meijer

Role: primary

Fennie Wit

Role: primary

Bert Bonsing

Role: primary

Ronald van Dam

Role: primary

Marion van der Kolk

Role: primary

Casper van Eijck

Role: primary

Erwin van der Harst

Role: primary

Hjalmar van Santvoort

Role: primary

Quintus Molenaar

Role: backup

Gijs Patijn

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Smits FJ, Molenaar IQ, Besselink MG, Busch OR, van Eijck CH, van Santvoort HC; Dutch Pancreatic Cancer Group. Management of postoperative pancreatic fistula after pancreatoduodenectomy: high mortality after completion pancreatectomy: Reply to: Bressan et al. completion pancreatectomy in the acute management of pancreatic fistula after pancreaticoduodenectomy. HPB (Oxford). 2018 Dec;20(12):1223. doi: 10.1016/j.hpb.2018.05.015. Epub 2018 Jun 22. No abstract available.

Reference Type DERIVED
PMID: 29941289 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UU2017-8272

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

W17.057

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ENROLLING_BY_INVITATION